Showing results (51-60 of 234) with videos related to
Sort By:
Pageof 24
Annals of Hematology|June 29, 2018
The co-occurrence of driver mutations in chronic myeloproliferative neoplasmsPrajwal Boddu, Dai Chihara, Lucia Masarova, et al.Bioorganic & Medicinal Chemistry|August 29, 2017
Lipase-catalyzed asymmetric synthesis of naphtho[2,3-c]furan-1(3H)-one derivatives by a one-pot dynamic kinetic resolution/intramolecular Diels-Alder reaction: Total synthesis of (-)-himbacineKoji Sugiyama, Shinji Kawanishi, Yasuhiro Oki, et al.European Journal of Haematology|August 12, 2008
Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximabYasuhiro Oki, Kazuhito Yamamoto, Harumi Kato, et al.American Journal of Hematology|May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaborationChan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.Haematologica|July 28, 2006
Mutations and promoter methylation status of NPM1 in myeloproliferative disordersYasuhiro Oki, Jaroslav Jelinek, Miloslav Beran, et al.Cancer|June 24, 2005
Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphomaYasuhiro Oki, Peter McLaughlin, Barbara Pro, et al.Journal of Epidemiology|August 5, 2014
Incidence of myelodysplastic syndrome in JapanDai Chihara, Hidemi Ito, Kota Katanoda, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2014
Predictive value of circulating angiopoietin-2 for endothelial damage-related complications in allogeneic hematopoietic stem cell transplantationNorihiro Ueda, Dai Chihara, Akio Kohno, et al.Blood Advances|July 2, 2024
Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population-based analysisJorge A Florindez, Dai Chihara, Isildinha M Reis, et al.British Journal of Haematology|August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphomaDai Chihara, Barbara Pro, Sanam Loghavi, et al.Pageof 24